Defining personal utility in genomics: A Delphi study.
- Publisher:
- WILEY
- Publication Type:
- Journal Article
- Citation:
- Clin Genet, 2017, 92, (3), pp. 290-297
- Issue Date:
- 2017-09
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
Clinical Genetics - 2017 - Kohler - Defining personal utility in genomics A Delphi study.pdf | Published version | 1.05 MB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Kohler, JN | |
dc.contributor.author |
Turbitt, E https://orcid.org/0000-0002-6650-9702 |
|
dc.contributor.author | Lewis, KL | |
dc.contributor.author | Wilfond, BS | |
dc.contributor.author | Jamal, L | |
dc.contributor.author | Peay, HL | |
dc.contributor.author | Biesecker, LG | |
dc.contributor.author | Biesecker, BB | |
dc.date.accessioned | 2022-04-19T02:04:52Z | |
dc.date.available | 2017-02-14 | |
dc.date.available | 2022-04-19T02:04:52Z | |
dc.date.issued | 2017-09 | |
dc.identifier.citation | Clin Genet, 2017, 92, (3), pp. 290-297 | |
dc.identifier.issn | 0009-9163 | |
dc.identifier.issn | 1399-0004 | |
dc.identifier.uri | http://hdl.handle.net/10453/156404 | |
dc.description.abstract | BACKGROUND: Individual genome sequencing results are valued by patients in ways distinct from clinical utility. Such outcomes have been described as components of "personal utility," a concept that broadly encompasses patient-endorsed benefits, that is operationally defined as non-clinical outcomes. No empirical delineation of these outcomes has been reported. AIM: To address this gap, we administered a Delphi survey to adult participants in a National Institute of Health (NIH) clinical exome study to extract the most highly endorsed outcomes constituting personal utility. MATERIALS AND METHODS: Forty research participants responded to a Delphi survey to rate 35 items identified by a systematic literature review of personal utility. RESULTS: Two rounds of ranking resulted in 24 items that represented 14 distinct elements of personal utility. Elements most highly endorsed by participants were: increased self-knowledge, knowledge of "the condition," altruism, and anticipated coping. DISCUSSION: Our findings represent the first systematic effort to delineate elements of personal utility that may be used to anticipate participant expectation and inform genetic counseling prior to sequencing. The 24 items reported need to be studied further in additional clinical genome sequencing studies to assess generalizability in other populations. Further research will help to understand motivations and to predict the meaning and use of results. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | WILEY | |
dc.relation.ispartof | Clin Genet | |
dc.relation.isbasedon | 10.1111/cge.12998 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 0604 Genetics, 1103 Clinical Sciences | |
dc.subject.classification | Genetics & Heredity | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Delphi Technique | |
dc.subject.mesh | Exome | |
dc.subject.mesh | Female | |
dc.subject.mesh | Genome, Human | |
dc.subject.mesh | Genomics | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Precision Medicine | |
dc.subject.mesh | Socioeconomic Factors | |
dc.subject.mesh | Surveys and Questionnaires | |
dc.subject.mesh | Whole Exome Sequencing | |
dc.subject.mesh | Whole Genome Sequencing | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Genomics | |
dc.subject.mesh | Genome, Human | |
dc.subject.mesh | Socioeconomic Factors | |
dc.subject.mesh | Delphi Technique | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Female | |
dc.subject.mesh | Male | |
dc.subject.mesh | Exome | |
dc.subject.mesh | Surveys and Questionnaires | |
dc.subject.mesh | Precision Medicine | |
dc.subject.mesh | Whole Genome Sequencing | |
dc.subject.mesh | Whole Exome Sequencing | |
dc.title | Defining personal utility in genomics: A Delphi study. | |
dc.type | Journal Article | |
utslib.citation.volume | 92 | |
utslib.location.activity | Denmark | |
utslib.for | 0604 Genetics | |
utslib.for | 1103 Clinical Sciences | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health/Graduate School of Health | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health/Graduate School of Health/GSH.Genetic Counselling | |
utslib.copyright.status | closed_access | * |
dc.date.updated | 2022-04-19T02:04:50Z | |
pubs.issue | 3 | |
pubs.publication-status | Published | |
pubs.volume | 92 | |
utslib.citation.issue | 3 |
Abstract:
BACKGROUND: Individual genome sequencing results are valued by patients in ways distinct from clinical utility. Such outcomes have been described as components of "personal utility," a concept that broadly encompasses patient-endorsed benefits, that is operationally defined as non-clinical outcomes. No empirical delineation of these outcomes has been reported. AIM: To address this gap, we administered a Delphi survey to adult participants in a National Institute of Health (NIH) clinical exome study to extract the most highly endorsed outcomes constituting personal utility. MATERIALS AND METHODS: Forty research participants responded to a Delphi survey to rate 35 items identified by a systematic literature review of personal utility. RESULTS: Two rounds of ranking resulted in 24 items that represented 14 distinct elements of personal utility. Elements most highly endorsed by participants were: increased self-knowledge, knowledge of "the condition," altruism, and anticipated coping. DISCUSSION: Our findings represent the first systematic effort to delineate elements of personal utility that may be used to anticipate participant expectation and inform genetic counseling prior to sequencing. The 24 items reported need to be studied further in additional clinical genome sequencing studies to assess generalizability in other populations. Further research will help to understand motivations and to predict the meaning and use of results.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph